Retinoblastoma. A survivor 12 years after treatment for metastatic disease.
A 21-year-old man currently is well 12 years after his last treatment for metastatic retinoblastoma.
D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000556:secondary*; D002648:Child; D002675:Child, Preschool; D005134:Eye Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D008854:Microscopy, Electron; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011878:Radiotherapy; D012175:Retinoblastoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D014265:Triethylenemelamine / Q000627:therapeutic use; D014457:Ulna / Q000601:surgery
D014265:Triethylenemelamine